The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 27th 2025
The FDA's approvals follows new COVID-19 guidance announced by the commissioner of the agency in May 2025, focusing future approvals on older adults.
New Jersey Veterinarians Urged to Help Prevent Abuse of Pet Prescriptions
October 12th 2017Officials with the New Jersey Attorney General’s office are calling on veterinarians to help combat the opioid epidemic, announcing stricter guidelines aimed at preventing individuals from abusing prescription medications meant for their pets.
Read More
Congress Urges Elimination of DIR Fees
October 12th 2017Several members of Congress recently sent a letter to the Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) that urged the elimination of direct and indirect remuneration (DIR) fees.
Read More
NCPA Offers Senate Committee Prescriptions for Addressing the Opioid Crisis
October 6th 2017The National Community Pharmacists Association (NCPA) shared with Congress eight recommendations for leveraging independent community pharmacists' knowledge and proximity to patients to help address the opioid crisis.
Read More
Bictegravir Combo Treatment Non-inferior to Boosted Protease Inhibitors in HIV?
October 5th 2017A fixed-dose combination of bictegravir and emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) was non-inferior to boosted protease inhibitor (bPI)-based regimens in virologically suppressed adults with HIV, according to a recently-published phase 3 study.
Read More